[2019] To find out why the committee made the 2019 recommendations on antihypertensive treatment during breastfeeding and how they might affect practice, see rationale and impact. 1.10 Advice and follow-up at transfer to community care Risk of recurrence of hypertensive disorders of pregnancy 1.10.1 Advise women with hypertensive disorders of pregnancy that the overall risk of recurrence in future pregnancies is approximately 1 in 5 (see Table 5 Likelihood of recurrence of hypertensive disorders of pregnancy Type of hypertension in previous or current pregnancy Prevalence of hypertensive disorder in a future pregnancy Any hypertension in pregnancy Pre-eclampsia Gestational hypertension Any hypertension Approximately Approximately Pre-eclampsia Approximately Up to approximately If birth was at 28 34 weeksa : approximately If birth was at 34 37 weeks: approximately Approximately Gestational hypertension Approximately women) Between approximately 6 and (up to 1 in 8 women) Between approximately (up to 1 in 7 women) Chronic hypertension Not applicable (up to 1 in 50 women) Approximately (up to 1 in 34 women) a No evidence was identified for women who gave birth at less than 28 weeks, but the committee agreed that the risk was likely to be at least as high, if not higher, than that for women who gave birth between 28 and 34 weeks. Long-term risk of cardiovascular disease 1.10.2 Advise women who have had a hypertensive disorder of pregnancy that this is associated with an increased risk of hypertension and cardiovascular disease in later life (see table 6). 